Drug Profile
Research programme: growth hormone releasing peptide analogues - Ardana
Alternative Names: EP 80317; Growth hormone releasing peptide analogues research programme - ArdanaLatest Information Update: 07 Feb 2005
Price :
$50
*
At a glance
- Originator Ardana Bioscience
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 07 Feb 2005 Discontinued - Preclinical for Cardiovascular disorders in Canada (unspecified route)
- 07 Feb 2005 Discontinued - Preclinical for Cardiovascular disorders in France (unspecified route)
- 15 Sep 2004 Preclinical studies have been added to the Ischaemic Heart Disease pharmacodynamics section ,